Showing 1 - 4 results of 4 for search 'Biyi Shen', query time: 0.04s
Refine Results
-
1
-
2
PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYM... by Eliza A. Hawkes, Tae Min Kim, Manjusha Namuduri, Ashish Risal, Biyi Shen, Dina Flink, Min Zhu, Siobhán Nolan, Jurriaan Brouwer-Visser, Aafia Chaudhry, Srikanth Ambati, Hesham Mohamed, Seok-Goo Cho
Published 2023-08-01
Article -
3
PB2266: TRIAL IN PROGRESS: PHASE 3 TRIAL OF ODRONEXTAMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA... by Umberto Vitolo, Elizabeth H. Phillips, Aránzazu Alonso Alonso, Michele Merli, Ashish Risal, Manjusha Namuduri, Biyi Shen, Dina Flink, Min Zhu, Sushmita Mukherjee, Jurriaan Brouwer-Visser, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Raul Cordoba
Published 2023-08-01
Article -
4
Nonadherence to Multimodality Cancer Treatment Guidelines in the United States by Leila T. Tchelebi, MD, Biyi Shen, MS, Ming Wang, PhD, Louis Potters, MD, Joseph Herman, MD, Daniel Boffa, MD, Joel E. Segel, PhD, Henry S. Park, MD, MPH, Nicholas G. Zaorsky, MD, MS
Published 2022-09-01
Article